DCF — PROV ST MARY MEDICAL CENTER
Enterprise Value: $-385.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-385.6M
Enterprise Value
$-121.2M
PV of Cash Flows
$-264.4M
PV of Terminal Value
$-425.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $217.8M | $-24.5M | -11.0% | $-33.7M | $-30.6M |
| Year 2 | $224.4M | $-22.9M | -10.0% | $-32.4M | $-26.8M |
| Year 3 | $231.1M | $-21.3M | -9.0% | $-31.1M | $-23.4M |
| Year 4 | $238.0M | $-20.8M | -9.0% | $-30.8M | $-21.1M |
| Year 5 | $245.2M | $-20.8M | -8.0% | $-31.2M | $-19.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-385.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$211.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11726090742460168
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5